The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and IndonesiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Mixed vaccination strategy for the control of tuberculosis: A case study in ChinaFriday, August 9, 2024Availability, Epidemiological impactRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and IndiaFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.Friday, August 9, 2024Availability, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in the U.S.Friday, August 9, 2024Availability, Epidemiological impactRead More
TB case-finding in the context of future vaccinesFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Is neglect of self-clearance biasing TB vaccine impact estimates?Friday, August 9, 2024Availability, Epidemiological impactRead More